Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments

BACKGROUND: Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKnife trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackeprang, P.-H., Vuong, D., Volken, W., Henzen, D., Schmidhalter, D., Malthaner, M., Mueller, S., Frei, D., Kilby, W., Aebersold, D. M., Fix, M. K., Manser, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/
https://www.ncbi.nlm.nih.gov/pubmed/31533746
http://dx.doi.org/10.1186/s13014-019-1370-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751815/
https://www.ncbi.nlm.nih.gov/pubmed/31533746
http://dx.doi.org/10.1186/s13014-019-1370-5

Ejemplares similares